purinergic receptor P2Y12 ; Homo sapiens






1289 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1737752 Low structural specificity for nucleoside triphosphates as antagonists of ADP-induced platelet activation. J Biol Chem 1992 Feb 15 2
2 7945429 Effects of extracellular divalent cations on responses of human blood platelets to adenosine 5'-diphosphate. Biochem Pharmacol 1994 Oct 7 2
3 9653141 Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci U S A 1998 Jul 7 1
4 10440415 Single-dose pharmacodynamics of clopidogrel. Semin Thromb Hemost 1999 1
5 10440416 Repeated-dose pharmacodynamics of clopidogrel in healthy subjects. Semin Thromb Hemost 1999 1
6 10446085 Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel. Arterioscler Thromb Vasc Biol 1999 Aug 8
7 10506165 Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. J Biol Chem 1999 Oct 8 3
8 10544922 Role of intracellular signaling events in ADP-induced platelet aggregation. Thromb Haemost 1999 Oct 4
9 10751543 On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP. Biochem Pharmacol 2000 Jun 1 2
10 10960076 ADP is not an agonist at P2X(1) receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. Br J Pharmacol 2000 Sep 2
11 11104774 ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 2001 Mar 16 9
12 11215376 [Aggregation of human blood platelets by remnant-like lipoprotein particles]. Nihon Yakurigaku Zasshi 2000 Nov 1
13 11245644 Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial. Circulation 2001 Mar 13 1
14 11413167 Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001 Jun 1
15 11454254 The P2Y12 receptor as a therapeutic target in cardiovascular disease. Platelets 2001 Jun 6
16 11459636 Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y(12)). Bioorg Med Chem Lett 2001 Jul 23 2
17 11502873 Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor. Mol Pharmacol 2001 Sep 8
18 11756171 Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors. Blood 2002 Jan 1 4
19 11815620 A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets. J Biol Chem 2002 Apr 5 1
20 11950711 Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood. Arterioscler Thromb Vasc Biol 2002 Apr 1 3
21 12353080 Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin. Thromb Haemost 2002 Sep 2
22 12560222 Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270. Blood 2003 May 15 25
23 12578987 Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. Proc Natl Acad Sci U S A 2003 Feb 18 8
24 12588350 Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP. Br J Haematol 2003 Feb 1
25 12615691 In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability. Arterioscler Thromb Vasc Biol 2003 Mar 1 3
26 12806027 P2 receptors and platelet activation. ScientificWorldJournal 2002 Feb 13 2
27 12812379 The effect of a loading dose (300 mg) of clopidogrel on platelet function in patients with peripheral arterial disease. Clin Appl Thromb Hemost 2003 Apr 1
28 12912815 Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003 Aug 26 2
29 12913786 Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis. Curr Opin Hematol 2003 Sep 6
30 14573771 Purification and functional reconstitution of the human P2Y12 receptor. Mol Pharmacol 2003 Nov 4
31 14597584 Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis. Circulation 2003 Nov 25 1
32 14610915 ADP receptor antagonists as antiplatelet therapeutics. Expert Opin Emerg Drugs 2003 May 6
33 14645014 The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. Blood 2004 Apr 1 4
34 14662702 P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study. Circulation 2003 Dec 16 2
35 14670370 Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1. Cell Calcium 2004 Jan 3
36 14706855 Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation. FEBS Lett 2004 Jan 2 4
37 14717977 Gi-dependent and -independent mechanisms downstream of the P2Y12 ADP-receptor. J Thromb Haemost 2004 Jan 4
38 15140134 Different G protein-coupled signaling pathways are involved in alpha granule release from human platelets. J Thromb Haemost 2004 Jun 2
39 15154604 The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Platelets 2004 Mar 1
40 15187029 Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets. Blood 2004 Sep 15 1
41 15203713 Collagen-induced generation of platelet-derived microparticles in whole blood is dependent on ADP released from red blood cells and calcium ions. Platelets 2004 Jun 3
42 15213852 ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets. Thromb Haemost 2004 Jul 5
43 15265806 Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation. Br J Pharmacol 2004 Aug 2
44 15269827 Pharmacokinetics of clopidogrel after administration of a high loading dose. Thromb Haemost 2004 Aug 1
45 15291969 P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 2004 Aug 3 1
46 15308557 ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 2004 Oct 3
47 15333577 Platelet adhesion and signaling induced by the octapeptide primary binding sequence (KOGEOGPK) from type III collagen. FASEB J 2004 Sep 1
48 15345752 Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog. J Pharmacol Exp Ther 2004 Dec 3
49 15481977 Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J Med Chem 2004 Oct 21 1
50 15583724 Variable extent of clopidogrel responsiveness in patients after coronary stenting. Thromb Haemost 2004 Dec 2